AABB is urging hospitals to remain highly vigilant in managing their blood inventories, especially type O negative red blood cells and AB plasma, as these products are in short supply this summer. AABB recommends hospitals reserve AB plasma for blood group AB patients with definitive transfusion needs. For situations where type O negative red blood cells and AB plasma are used as part of a massive transfusion protocol for patients of unknown blood type, every effort should be made to obtain a blood type for the patient as soon as possible. “Maintaining a safe and adequate blood supply is critical to the nation’s public health and a priority for the medical community,” said Miriam A. Markowitz, CEO of AABB. Hospitals are urged to follow available clinical practice guidelines for the appropriate use of individual blood products. AHA and AABB collaborated on a toolkit to assist hospitals as they implement a patient blood management approach as a component of their care planning decisions. 

Related News Articles

Headline
The Centers for Medicare & Medicaid Services July 2 announced that Maryland, Vermont and Connecticut will be the first participants in the States Advancing…
Headline
In a new “Safety Speaks” conversation, Harry S. Smith, board chair of Valley Health System and member of the AHA Committee on Governance, discusses how Valley…
Headline
The Healthcare Equality Network July 3 sent a letter to the Centers for Medicare & Medicaid Services, expressing concerns about claims denials by…
Headline
The Substance Abuse and Mental Health Services Administration June 8 announced the availability of $27.5 million in funding opportunities focused on improving…
Headline
The Centers for Medicare & Medicaid Services July 8 announced over 400 participants in a new model focused on improving dementia care. The Guiding an…
Headline
A federal court in Texas last week found that the Federal Trade Commission likely lacked statutory authority to issue its Non-Compete Clause Final Rule. The…